Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Thorne

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Global Heart|February 18, 2021
Prevalence of Rheumatic Heart Disease and Other Cardiac Conditions in Low-Risk Pregnancies in Kenya: A Prospective Echocardiography Screening StudyJohn W Snelgrove, Joy Marsha Alera, Michael C Foster, et al.
Nature Microbiology|January 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsAnn-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan, et al.
Elife|October 24, 2023
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomesXiang Wang, Vitaliy V Bondar, Oliver B Davis, et al.
Nature Communications|February 10, 2025
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCVLydia S Newton, Clara Gathmann, Sophie Ridewood, et al.
Biotechnology for Biofuels|June 18, 2016
Strain and bioprocess improvement of a thermophilic anaerobe for the production of ethanol from woodChristopher D Herring, William R Kenealy, A Joe Shaw, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variantAnn-Kathrin Reuschl, Lucy G Thorne, Lorena Zuliani-Alvarez, et al.
EMBO Reports|August 24, 2022
Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spikeDiego Cantoni, Matthew J Murray, Mphatso D Kalemera, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Communications|February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 16, 2025
Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer's mouse modelVanessa O Torres, Michelle E Pizzo, Darren Chan, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Global Heart|February 18, 2021
Prevalence of Rheumatic Heart Disease and Other Cardiac Conditions in Low-Risk Pregnancies in Kenya: A Prospective Echocardiography Screening StudyJohn W Snelgrove, Joy Marsha Alera, Michael C Foster, et al.
Nature Microbiology|January 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsAnn-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan, et al.
Elife|October 24, 2023
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomesXiang Wang, Vitaliy V Bondar, Oliver B Davis, et al.
Nature Communications|February 10, 2025
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCVLydia S Newton, Clara Gathmann, Sophie Ridewood, et al.
Biotechnology for Biofuels|June 18, 2016
Strain and bioprocess improvement of a thermophilic anaerobe for the production of ethanol from woodChristopher D Herring, William R Kenealy, A Joe Shaw, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variantAnn-Kathrin Reuschl, Lucy G Thorne, Lorena Zuliani-Alvarez, et al.
EMBO Reports|August 24, 2022
Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spikeDiego Cantoni, Matthew J Murray, Mphatso D Kalemera, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Communications|February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 16, 2025
Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer's mouse modelVanessa O Torres, Michelle E Pizzo, Darren Chan, et al.
Pageof 13